Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.28 USD | -0.96% | -3.60% | -18.31% |
Apr. 17 | UBS Adjusts Gilead Sciences Price Target to $75 From $81, Maintains Neutral Rating | MT |
Apr. 15 | Goldman Sachs Adjusts Gilead Sciences Price Target to $73 From $76 | MT |
Financials (USD)
Sales 2024 * | 27.51B | Sales 2025 * | 27.96B | Capitalization | 83.46B |
---|---|---|---|---|---|
Net income 2024 * | 6.18B | Net income 2025 * | 6.84B | EV / Sales 2024 * | 3.51 x |
Net Debt 2024 * | 13.09B | Net Debt 2025 * | 7.12B | EV / Sales 2025 * | 3.24 x |
P/E ratio 2024 * |
13.9
x | P/E ratio 2025 * |
12.1
x | Employees | 18,000 |
Yield 2024 * |
4.69% | Yield 2025 * |
4.89% | Free-Float | 99.9% |
Latest transcript on Gilead Sciences, Inc.
1 day | -0.56% | ||
1 week | -1.75% | ||
Current month | -8.63% | ||
1 month | -9.17% | ||
3 months | -22.61% | ||
6 months | -16.84% | ||
Current year | -17.38% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 58 | 19-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 54 | 15-12-31 |
Flavius Martin
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Welters
BRD | Director/Board Member | 69 | 20-10-16 |
Director/Board Member | 71 | 17-12-31 | |
Ted Love
BRD | Director/Board Member | 65 | Jan. 31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.99% | 215 M€ | +12.15% | - | |
8.10% | 0 M€ | 0.00% | - | |
8.06% | 0 M€ | 0.00% | - | |
5.23% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 66.18 | -1.11% | 3 487 924 |
24-04-17 | 66.93 | -0.56% | 5,287,730 |
24-04-16 | 67.31 | -0.65% | 4,975,048 |
24-04-15 | 67.75 | -0.47% | 7,717,826 |
24-04-12 | 68.07 | -0.84% | 5,691,760 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.38% | 83.46B | |
+28.79% | 676B | |
+24.87% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.51% | 210B | |
-0.12% | 204B | |
-9.73% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- GILD Stock